This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CH STRONG is a project to gather information about care and quality of life from adults living with CHD. CHSTRONG KIDS gathers information about healthcare use, education, social experiences, and quality of life from families of children with heart defects.
We determined the utility of this score for predicting outcomes within one-year post-stroke/TIA.Methods:Analysis of adults with acute stroke/TIA (2012-2016) using linked data from the Australian Stroke Clinical Registry and administrative datasets (pharmaceutical, hospital, Medicare), as part of the PRECISE study.
Additional ACC.25 Details on abstracts presented by Bayer at ACC.25 Effect of finerenone on N-terminal pro-B-type natriuretic peptide in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial during the session "Finerenone: A Promising Addition to the Armamentarium or Merely an Academic Exercise?"
Surviving this long with a good quality of life is even rarer. 2012 Apr;67(4):395-405. Share One of the factors that has the biggest impact on healthspan and quality of life is whether you have a major chronic disease such as cancer, cardiovascular disease or dementia. 2012 Apr;67(4):395-405.
Additional ACC.25 Details on abstracts presented by Bayer at ACC.25 Effect of finerenone on N-terminal pro-B-type natriuretic peptide in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial during the session "Finerenone: A Promising Addition to the Armamentarium or Merely an Academic Exercise?"
Laurie Shroyer Single- Versus Multicenter Surgeons' Risk-Adjusted Coronary Artery Bypass Graft Procedural Outcomes The Annals of Thoracic Surgery May 2018 Thomas Schwann Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting The Annals of Thoracic Surgery April 2018 Alexander Brescia Determinants of Variation in Pneumonia (..)
Laurie Shroyer 1 Single- Versus Multicenter Surgeons' Risk-Adjusted Coronary Artery Bypass Graft Procedural Outcomes The Annals of Thoracic Surgery May 2018 Thomas Schwann Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting The Annals of Thoracic Surgery April 2018 Alexander Brescia Determinants of Variation in Pneumonia (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content